Canada markets closed

Amneal Pharmaceuticals, Inc. (2DT.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
6.50-0.05 (-0.76%)
At close: 03:29PM CEST
Show:
Income Statement
Cash Flow
Annual

Balance Sheet

Currency in USD. All numbers in thousands
Breakdown
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Assets
Current Assets
Cash
Cash And Cash Equivalents
91,542
25,976
247,790
341,378
-
Total Cash
91,542
25,976
247,790
341,378
-
Net Receivables
613,732
741,791
662,583
638,895
-
Inventory
581,384
530,735
489,389
490,649
-
Total Current Assets
1,377,863
1,411,818
1,520,108
1,551,539
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
1,058,164
1,035,331
1,033,565
936,849
-
Accumulated Depreciation
-508,027
-445,971
-394,562
-332,139
-
Net property, plant and equipment
550,137
589,360
639,003
604,710
-
Goodwill
598,629
598,853
593,017
522,814
-
Intangible Assets
890,423
1,096,093
1,166,922
1,304,626
-
Other long-term assets
7,126
8,191
9,220
6,858
-
Total non-current assets
2,094,706
2,387,523
2,419,556
2,454,494
-
Total Assets
3,472,569
3,799,341
3,939,664
4,006,033
-
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Current Debt
213,125
89,961
30,614
45,228
-
Accounts Payable
143,572
165,980
131,084
153,140
-
Accrued liabilities
309,742
307,955
319,414
384,041
-
Other Current Liabilities
76,988
107,483
58,000
-
-
Total Current Liabilities
846,595
752,800
677,243
676,902
-
Non-current liabilities
Long Term Debt
2,427,451
2,631,687
2,718,091
2,771,704
-
Deferred taxes liabilities
-
-
-
-
0
Other long-term liabilities
8,215
70,168
2,664
5,855
-
Total non-current liabilities
2,605,963
2,862,562
2,895,448
2,984,199
-
Total Liabilities
3,452,558
3,615,362
3,572,691
3,661,101
-
Stockholders' Equity
Common Stock
3,066
3,036
3,014
2,997
-
Retained Earnings
-490,176
-406,183
-276,197
-286,821
-
Accumulated other comprehensive income
-32,349
9,939
-24,827
-41,318
-
Total stockholders' equity
19,781
298,421
360,340
303,271
-
Total liabilities and stockholders' equity
3,472,569
3,799,341
3,939,664
4,006,033
-